Peripheral blood biomarkers in Immune Checkpoint Inhibition therapy in Metastatic Melanoma
Preprint in Research Square (May 2023)
The most recent citing publications are shown below. View all 79 publications that cite this research output on Dimensions.
Hypofractionated Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.
Article in The Oncologist (May 2023)
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
Article in Cancers (May 2023)